Remepy

Research51-200seedחברה ישראלית
2022
נוסדה
6
משרות פתוחות
seed
שלב
ABOUT

Remepy

Remepy is a global leader in hybrid drug development, specializing in the integration of traditional pharmaceuticals with clinically validated digital therapeutics. Their innovative approach enhances patient outcomes for conditions such as Parkinson’s Disease, oncology, and immunology. Remepy’s trademarked **Hybrid Drugs** combine pharmaceutical molecules with app-based protocols, improving motor, cognitive, mental, and speech functions. The company has developed **Hybridopa**, the world’s first hybrid drug for Parkinson’s Disease, which combines Levodopa with a digital protocol. Remepy also offers a broader portfolio of hybrid drugs that provide comprehensive biological and behavioral therapy, demonstrating validated improvements in patient outcomes. Their commitment to regulatory compliance is evident through adherence to PDURS standards, ensuring that their products meet FDA requirements. With a team of top scientists, physicians, and technologists, Remepy aims to deliver better personalized care worldwide.

JOIN

רוצים גישה למאגר המלא?
היכנסו הביתה.

חברי בית מקבלים גישה למאגר חברות, משרות, מחקר קהילתי והערות פרטיות — הכל במקום אחד.